Browse the latest stories and reports on MSF from various media outlets.

Country/Region

September 13, 2017

9 News interviews Dr. John Lawrence, president of the board of Doctors Without Borders/Médecins Sans Frontières (MSF) about their new exhibition called Forced From Home. Visitors navigate a 10,000-square-foot installation designed to convey some of the challenges confronting a person forced to flee. View External Media

October 05, 2016

CBS tours Forced From Home, Doctors Without Borders/Médecins Sans Frontières (MSF) exhibit on the global refugee crisis.

October 03, 2016

Doctors Without Borders/Médecins Sans Frontières (MSF) has recently launched an interactive educations exhibit about the global refugee crisis on the National Mall, Washington, DC. The exhibit is free and open to the public through October 9. View external media. 

June 28, 2013

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

April 02, 2013

  A landmark ruling by India's Supreme Court underscores the need for patients to have access to generic medications at affordable prices, according to MSF's Jennifer Cohn.

March 18, 2013

  MSF's Fabio Forgione describes the humanitarian crisis facing the approximately 400,000 Syrian refugees in Lebanon, with many more arriving daily.

February 15, 2013

  MSF is calling attention to the lack of basic assistance for Syrian refugees in Lebanon, including shelter and medical care.

February 08, 2013

MSF warns that a lack of shelter and medical care is threatening the health of Syrian refugees in Lebanon, who now number more than 260,000.  

February 07, 2013

  MSF is calling for the Lebanese government and the U.N. High Commissioner for Refugees to speed up the process for registering Syrian refugees and providing for their basic needs.

August 21, 2012

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

Pages